BetaShares Global Healthcare Currency Hedged ETF is a sector & thematic ETF from BetaShares — 66 holdings, with $163.0m under management. 98% of its money is in health care. Its two largest holdings, ELI LILLY & CO and JOHNSON & JOHNSON, make up 16% of the fund. It charges 0.57% a year.
Compare DRUG with another fund →About DRUG
- TypeSector & thematic
- IssuerBetaShares
- Size$163.0m
- Cost0.57% a year
- Holdings66
- Top sectorHealth Care 98%
- Top 2 holdings16%
Last month+2.3%
$8.93+2.29% price
DRUG rose 2.3% over the last month. On $10,000, that's +$229. NOVOB was the biggest drag at −$27; ABBV helped most at +$57.
1M high$9.00
1M low$8.68
Avg volume60k
Latest volume263k
Prices to 12 Oct closeNo distributions in this period
What moved it
Gain or loss per $10k invested
- ABBVAbbVie+$57
- LLYEli Lilly+$39
- ISRGIntuitive+$35
- TMOThermo Fisher+$34
- NOVOBNovo Nordisk−$27
- AMGNAmgen+$25
- NOVNNovartis+$22
- Other 55 holdings+$128
- Other 53 holdings+$81
- UnattributedHedging, fees, timing−$33
- CompoundingDaily returns multiply, they do not add−$3
- Fund return+$229
- Other 2 kinds of news+$5
Each kind of news counts the days those moves happened; No flagged news is every other day. News is tracked for moves large enough to be flagged; most international holdings had none in this range.
All 66 holdings
HideCodeWeightContribution, 1M
Loading every holding…
Country
per $10k
- Other 4 countries−$11
- Other 2 countries+$2